Sanofi
SNYNF
|
News
|
$108.84
|
|
Health Technology
(0.0% 1d) (1.5% 1m) (17.7% 1y) (0.0% 2d) (0.0% 3d) (4.2% 7d) (-35.63% volume)
Earnings Calendar:
http://www.sanofi.com
Sec Filling | Patents | n/a employees
(FR) Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine diabetic diabetes
add to watch list email alert is off
Price chart
% (High / Open) change chart
Press-releases
Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
Published: 2022-06-28 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
CLLS | News | $2.92 -9.03% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
RLAY | News S | $16.38 -12.27% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
United States Human Vaccines Markets, 2018-2021 & Forecast to 2028: Approval/launches of the New Vaccines / Rising Focus on Immunization Programs / Increasing Investments and Government Support
Published: 2022-06-28 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
DVAX | News | $12.18 -2.56% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
Survey: Digital Workplaces Help Frontline Teams Look Beyond the "Big Quit"
Published: 2022-06-28 (Crawled : 15:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati
Published: 2022-06-28 (Crawled : 13:00) - contravir.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
HEPA | News | $0.6549 -2.6% 1.13% |
|
Health Technology
|
| O: -1.17%
H: 1.49%
C: -2.99%
G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
Published: 2022-06-28 (Crawled : 12:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
GTHX | News A | $5.19 -2.99% -0.37% |
|
Health Technology
|
| O: -2.37%
H: 3.18%
C: -3.18%
therapeutics
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
xenpozyme treatment for approved
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
nexviadyme treatment care disease for approved potential
Sanofi Enters into a Partnering Agreement with Health2Sync
Published: 2022-06-28 (Crawled : 04:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
agreement sanofi
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
ABBV | News | $152.49 -0.42% 0.0% |
|
Health Technology
|
| O: 0.06%
H: 1.27%
C: -0.44%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
pharma
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Published: 2022-06-27 (Crawled : 21:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistLast 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% |
|
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 0.0% |
|
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% -0.43% |
|
Electronic Technology
| 16:00